Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02724787 · ClinicalTrials.gov registry record · NA
Using Emotion Regulation to Decrease Aggression in Veterans With PTSD
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02724787: Completed NA study, sponsored by VA Office of Research and Development.
NCT02724787 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02724787, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Impulsive aggression (IA) is common among Veterans with posttraumatic stress disorder (PTSD), and PTSD is one of the most prevalent post deployment mental health conditions affecting Afghanistan and Iraq Veterans. An inability to manage one's emotions (emotion dysregulation) is an underlying mechanism of IA. Reducing IA and increasing use of PTSD evidence-based psychotherapies are two critical missions for the Veterans Health Administration. This research supports these missions by providing a 3-session emotion regulation training (Manage Emotions to Reduce Aggression) to Veterans in order to teach them how to manage emotions and prepare for PTSD treatment. This is an open trail, so all Veterans who meet the inclusion criteria will be allowed to receive the treatment. Each Veteran's level of aggression and emotion dysregulation will be measured at the beginning and end to the treatment. By enhancing Veterans' abilities to cope with trauma-related emotions and feel equipped to initiate PTSD treatments, this research aims to help Veterans decrease IA and ultimately recover from PTSD.
Interventions
- BEHAVIORAL Manage Emotions to Reduce Aggression (MERA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-06-13 |
| Est. Completion | 2018-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02724787
The ClinicalTrials.gov registry entry for NCT02724787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Manage Emotions to Reduce Aggression (MERA) is the first listed.
NCT02724787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02724787 about?
NCT02724787 is a clinical study titled "Using Emotion Regulation to Decrease Aggression in Veterans With PTSD". Impulsive aggression (IA) is common among Veterans with posttraumatic stress disorder (PTSD), and PTSD is one of the most prevalent post deployment mental health conditions affecting Afghanistan and Iraq Veterans. An inability to manage one's emotions (emotion dysregulation) is an underlying mechani...
What is the current status of trial NCT02724787?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-06-13. Estimated completion is 2018-02-07.
What interventions are being tested in trial NCT02724787?
The interventions under investigation include: Manage Emotions to Reduce Aggression (MERA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02724787?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.